Genetic landscape of clear cell endometrial cancer and the era of precision medicine
- PMID: 28485840
- PMCID: PMC5907932
- DOI: 10.1002/cncr.30743
Genetic landscape of clear cell endometrial cancer and the era of precision medicine
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosure.
Comment on
-
Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.Cancer. 2017 Sep 1;123(17):3261-3268. doi: 10.1002/cncr.30745. Epub 2017 May 9. Cancer. 2017. PMID: 28485815 Free PMC article.
Similar articles
-
The genetic landscape of endometrial clear cell carcinomas.J Pathol. 2017 Oct;243(2):230-241. doi: 10.1002/path.4947. Epub 2017 Sep 5. J Pathol. 2017. PMID: 28718916 Free PMC article.
-
Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.Cancer Res. 2000 Dec 15;60(24):7052-6. Cancer Res. 2000. PMID: 11156411
-
Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.BMC Cancer. 2014 Nov 26;14:884. doi: 10.1186/1471-2407-14-884. BMC Cancer. 2014. PMID: 25427824 Free PMC article.
-
Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review.Gynecol Oncol. 2009 May;113(2):277-83. doi: 10.1016/j.ygyno.2009.02.003. Epub 2009 Feb 28. Gynecol Oncol. 2009. PMID: 19251307 Review.
-
Molecular carcinogenesis of endometrial cancer.Taiwan J Obstet Gynecol. 2007 Mar;46(1):26-32. doi: 10.1016/S1028-4559(08)60102-3. Taiwan J Obstet Gynecol. 2007. PMID: 17389185 Review.
Cited by
-
The role of TCGA molecular classification in clear cell endometrial carcinoma.Front Oncol. 2023 Jun 29;13:1147394. doi: 10.3389/fonc.2023.1147394. eCollection 2023. Front Oncol. 2023. PMID: 37456263 Free PMC article. Review.
-
Identifying clinical features and molecular characteristics of the endometrial clear cell carcinoma.Front Oncol. 2023 Nov 17;13:1286176. doi: 10.3389/fonc.2023.1286176. eCollection 2023. Front Oncol. 2023. PMID: 38045002 Free PMC article.
-
Carcinosarcoma of the Endometrium-Pathology, Molecular Landscape and Novel Therapeutic Approaches.Medicina (Kaunas). 2025 Jun 26;61(7):1156. doi: 10.3390/medicina61071156. Medicina (Kaunas). 2025. PMID: 40731786 Free PMC article. Review.
-
Expression and prognostic value of EGF-like domain multiple 6 in uterine corpus endometrial carcinoma and its correlation with immune cell infiltration.Sci Rep. 2025 Jul 2;15(1):22620. doi: 10.1038/s41598-025-07379-7. Sci Rep. 2025. PMID: 40595086 Free PMC article.
References
-
- Bae HS, Kim H, Young Kwon S, Kim K-R, Song JY, Kim I. Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma? Int J Gynecol Pathol. 2015;34:74–84. - PubMed
-
- Huang H-N, Chiang Y-C, Cheng W-F, Chen C-A, Lin M-C, Kuo K-T. Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation. Mod Pathol. 2015;28:303–311. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources